Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways
Endovia financing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-derived medicines
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Davidson Kempner Capital Management LP : Form 8.3 - DCC PLC
- Marimekko and VEJA announce limited-edition collaboration collection launching in November 2026
- Dynacor Group Announces October 2026 Dividend
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →